ARTHRITIS FOUNDATION

Medicare/Medicaid

out-of-pocket costs, drug prices, utilization management, prior authorization, step therapy, clinical trial diversity, COVID-19 therapeutics, pharmacist scope of practice, telehealth extensions , association health plans, self-insurance protections, short-term limited duration insurance plans -HR 830/S 1357,HELP Copays Act -HR 2630/ S. 652, Safe Step Act -S 1339, Pharmacy Benefit Manager Reform Act -HR 1770, the Equitable Community Access to Pharmacist Services Act -HR 824, the Telehealth Benefit Expansion for Workers Act -Accelerating Kid's Access to Care Act

TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Labor, Dept of (DOL) · Centers For Medicare and Medicaid Services (CMS)

Health Issues

-HR 830 / S 1357, HELP Copays Act -HR 2630 / S 652, Safe Step Act -S 1339, Pharmacy Benefit Manager Reform Act -H.R. 1770, the Equitable Community Access to Pharmacist Services Act -HR 824, the Telehealth Benefit Expansion for Workers Act -Accelerating Kids Access to Care Act - S. 127 Pharmacy Benefit Manager Transparency Act of 2023 - S. 1339 Pharmacy Benefit Manager Reform Act - H.R. 4507 Transparency in Coverage Act of 2023 - H.R. 4822 Health Care Price Transparency Act of 2023 - H.R. 3561 PATIENT Act of 2023 -H.R. 5378 - The Lower Costs, More Transparency Act - H.R. 2761 SPARC Act, Specialty Physicians Advancing Rural Care (SPARC) Act - S.1701/H.R.3503 NIH Clinical Trial Diversity Act of 2023 - H.R. 1114 Long COVID RECOVERY NOW Act - S.2840 the Bipartisan Primary Care and Health Workforce Act